Publicaciones en las que colabora con Antonio Juan Mas (22)

2024

  1. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

    Genome Biology, Vol. 25, Núm. 1

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

  2. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register

    RMD Open, Vol. 8, Núm. 2

  3. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

    eBioMedicine, Vol. 80

  4. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables

    Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096

2021

  1. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study

    Reumatologia Clinica, Vol. 17, Núm. 8, pp. 461-470

  2. Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice

    Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558

2020

  1. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

    Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916

  2. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

  3. Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study

    Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170

2019

  1. Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study

    Reumatologia Clinica, Vol. 15, Núm. 5, pp. 264-270

  2. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739

  3. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96

2017

  1. Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

    Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942

  2. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis

    Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

  2. Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580

  3. Evaluation of the impact of nursing clinics in the rheumatology services

    Rheumatology International, Vol. 36, Núm. 9, pp. 1309-1317

2008

  1. Observed and expected frequency of comorbid chronic diseases in rheumatic patients

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 3, pp. 418-421

  2. Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 2, pp. 324-332